KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 79 filers reported holding KRONOS BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,006 | -24.4% | 1,542,954 | 0.0% | 0.09% | +4.9% |
| Q2 2023 | $2,654 | +17.8% | 1,542,954 | 0.0% | 0.08% | -38.8% |
| Q1 2023 | $2,253 | -9.9% | 1,542,954 | 0.0% | 0.13% | -4.3% |
| Q4 2022 | $2,500 | -100.0% | 1,542,954 | 0.0% | 0.14% | -36.7% |
| Q3 2022 | $5,169,000 | -8.0% | 1,542,954 | 0.0% | 0.22% | -26.3% |
| Q2 2022 | $5,616,000 | -49.7% | 1,542,954 | 0.0% | 0.30% | -35.8% |
| Q1 2022 | $11,156,000 | -46.8% | 1,542,954 | 0.0% | 0.47% | -17.9% |
| Q4 2021 | $20,969,000 | -24.1% | 1,542,954 | +17.1% | 0.57% | -7.9% |
| Q3 2021 | $27,624,000 | -12.5% | 1,317,954 | 0.0% | 0.62% | -3.6% |
| Q2 2021 | $31,565,000 | -18.2% | 1,317,954 | 0.0% | 0.64% | -6.0% |
| Q1 2021 | $38,577,000 | -2.0% | 1,317,954 | 0.0% | 0.68% | -19.3% |
| Q4 2020 | $39,367,000 | – | 1,317,954 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $9,264,000 | 8.31% |
| Omega Fund Management, LLC | 3,818,283 | $12,791,000 | 4.68% |
| Privium Fund Management (UK) Ltd | 645,331 | $2,162,000 | 2.76% |
| Wildcat Capital Management, LLC | 1,438,232 | $4,818,000 | 1.85% |
| Nextech Invest Ltd. | 1,451,537 | $4,863,000 | 1.57% |
| Alphabet Inc. | 1,438,232 | $4,818,000 | 0.25% |
| Artal Group S.A. | 1,542,954 | $5,169,000 | 0.22% |
| Perceptive Advisors | 2,156,151 | $7,223,000 | 0.21% |
| Oasis Management Co Ltd. | 196,078 | $657,000 | 0.11% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $1,767,000 | 0.10% |